These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 20636455)

  • 1. Regulatory T cells are critical to tolerance induction in presensitized mouse transplant recipients through targeting memory T cells.
    Ge W; Jiang J; Liu W; Lian D; Saito A; Garcia B; Li XC; Wang H
    Am J Transplant; 2010 Aug; 10(8):1760-73. PubMed ID: 20636455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade of OX40/OX40L pathway combined with ethylene-carbodiimide-fixed donor splenocytes induces donor-specific allograft tolerance in presensitized recipients.
    Lai X; Yao Z; Ning F; Zhang L; Fang J; Li G; Xu L; Xiong Y; Liu L; Chen R; Ma J; Chen Z
    Ann Transl Med; 2020 Feb; 8(4):84. PubMed ID: 32175377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Memory T Cells Mediate Cardiac Allograft Vasculopathy and are Inactivated by Anti-OX40L Monoclonal Antibody.
    Wang H; Zhang Z; Tian W; Liu T; Han H; Garcia B; Li XC; Du C
    Cardiovasc Drugs Ther; 2014 Apr; 28(2):115-22. PubMed ID: 24254032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-CD45RB and donor-specific spleen cells transfusion inhibition allograft skin rejection mediated by memory T cells.
    Jian YQ; Ye J; Qi H; Deng CY; Deng SP; Li FR
    Immunol Cell Biol; 2017 Feb; 95(2):189-197. PubMed ID: 27616751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-OX40L monoclonal antibody prolongs secondary heart allograft survival based on CD40/CD40L and LFA-1/ICAM-1 blockade.
    Dai H; Peng F; Lin M; Xia J; Yu S; Lan G; Wang Y; Xie X; Fang C; Corbascio M; Qi Z; Peng L
    Transpl Immunol; 2015 Mar; 32(2):84-91. PubMed ID: 25613092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibody treatment to prolong the secondary cardiac allograft survival in alloantigen-primed mice.
    Xie B; Chen J; Wang F; Lan T; Wang Y; Xia J; Li Z; Xie Q; Huang R; Qi Z
    Scand J Immunol; 2010 May; 71(5):345-52. PubMed ID: 20500685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presensitized immune condition of host exaggerates prolonged cold ischemia-mediated injury of cardiac graft involving regulatory T cells.
    Gong W; Huang T; Ge F; Luo G; Yuan S; Gao D; Kong D
    Transplantation; 2013 Oct; 96(7):609-15. PubMed ID: 23880577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A diametric role for OX40 in the response of effector/memory CD4+ T cells and regulatory T cells to alloantigen.
    Kinnear G; Wood KJ; Fallah-Arani F; Jones ND
    J Immunol; 2013 Aug; 191(3):1465-75. PubMed ID: 23817421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous blockade of co-stimulatory signals, CD28 and ICOS, induced a stable tolerance in rat heart transplantation.
    Guo L; Fujino M; Kimura H; Funeshima N; Kitazawa Y; Harihara Y; Tezuka K; Makuuchi M; Suzuki S; Li XK
    Transpl Immunol; 2003; 12(1):41-8. PubMed ID: 14551031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb.
    Lu L; Li W; Zhong C; Qian S; Fung JJ; Thomson AW; Starzl TE
    Transplantation; 1999 Sep; 68(6):747-57. PubMed ID: 10515374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adoptive transfer of transplantation tolerance mediated by CD4+CD25+ and CD8+CD28- regulatory T cells induced by anti-donor-specific T-cell vaccination.
    Wang J; Zhang L; Tang J; Jiang S; Wang X
    Transplant Proc; 2008 Jun; 40(5):1612-7. PubMed ID: 18589160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GITR ligation blocks allograft protection by induced CD25+CD4+ regulatory T cells without enhancing effector T-cell function.
    Bushell A; Wood K
    Am J Transplant; 2007 Apr; 7(4):759-68. PubMed ID: 17391121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An immunotherapeutic strategy for prolonging graft survival in mice.
    Wang F; Li J; Wang D; Fu Q; Xiong YY; Huang HT; Liu LS; Wang CX
    Transpl Immunol; 2015 Oct; 33(2):84-94. PubMed ID: 26319678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intermittent antibody-based combination therapy removes alloantibodies and achieves indefinite heart transplant survival in presensitized recipients.
    Shariff H; Tanriver Y; Brown KL; Meader L; Greenlaw R; Mamode N; Jurcevic S
    Transplantation; 2010 Aug; 90(3):270-8. PubMed ID: 20571468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pretransplant infusion of mesenchymal stem cells prolongs the survival of a semiallogeneic heart transplant through the generation of regulatory T cells.
    Casiraghi F; Azzollini N; Cassis P; Imberti B; Morigi M; Cugini D; Cavinato RA; Todeschini M; Solini S; Sonzogni A; Perico N; Remuzzi G; Noris M
    J Immunol; 2008 Sep; 181(6):3933-46. PubMed ID: 18768848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Requirements for prolongation of allograft survival with regulatory T cell infusion in lymphosufficient hosts.
    Brennan TV; Tang Q; Liu FC; Hoang V; Bi M; Bluestone JA; Kang SM
    J Surg Res; 2011 Jul; 169(1):e69-75. PubMed ID: 21571317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New insights on OX40 in the control of T cell immunity and immune tolerance in vivo.
    Xiao X; Gong W; Demirci G; Liu W; Spoerl S; Chu X; Bishop DK; Turka LA; Li XC
    J Immunol; 2012 Jan; 188(2):892-901. PubMed ID: 22147766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic administration of anti-interleukin-10 antibody prolongs organ allograft survival in normal and presensitized recipients.
    Li W; Fu F; Lu L; Narula SK; Fung JJ; Thomson AW; Qian S
    Transplantation; 1998 Dec; 66(12):1587-96. PubMed ID: 9884244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined treatment with vitamin D3 and antibody agents suppresses secondary heart transplant rejection in the early postoperative period.
    Xie B; Ma Y; Xi Y; Di A; Chen X; Chen Y; Zhang L; Xu S; Wang C; Yan G; Qi Z
    Transpl Immunol; 2020 Apr; 59():101270. PubMed ID: 31953155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Costimulation blockade-induced cardiac allograft tolerance: inhibition of T cell expansion and accumulation of intragraft cD4(+)Foxp3(+) T cells.
    Oderup C; Malm H; Ekberg H; Qi Z; Veress B; Ivars F; Corbascio M
    Transplantation; 2006 Dec; 82(11):1493-500. PubMed ID: 17164722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.